kcl22 cell lines Search Results


90
KinaSense LLC cml cell lines kcl22 and kcl22-ir
Calculated LogP and anti-proliferation activities of alkynyl analogs
Cml Cell Lines Kcl22 And Kcl22 Ir, supplied by KinaSense LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kcl22+cell+lines/cml+cell+lines+kcl22+and+kcl22+ir/pmc06312196-305-14-16
Average 90 stars, based on 1 article reviews
cml cell lines kcl22 and kcl22-ir - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science human myeloid cell line kcl-22
Calculated LogP and anti-proliferation activities of alkynyl analogs
Human Myeloid Cell Line Kcl 22, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kcl22+cell+lines/human+myeloid+cell+line+kcl+22/pmc04866231-90-7-14
Average 90 stars, based on 1 article reviews
human myeloid cell line kcl-22 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Calculated LogP and anti-proliferation activities of alkynyl analogs

Journal: ChemMedChem

Article Title: Alkynylnicotinamide-based compounds as ABL1 inhibitors with potent activities against drug-resistant CML harboring ABL1(T315I) mutant kinase.

doi: 10.1002/cmdc.201700829

Figure Lengend Snippet: Calculated LogP and anti-proliferation activities of alkynyl analogs

Article Snippet: Evaluation of compounds activity against ABL1 and ABL1(T315I) inside CML cell lines KCL22 and KCL22-IR (by KinaSense, West Lafayette, IN, USA).

Techniques:

Inhibition of cellular ABL1 activity by imatinib, ponatinib and HSN compounds

Journal: ChemMedChem

Article Title: Alkynylnicotinamide-based compounds as ABL1 inhibitors with potent activities against drug-resistant CML harboring ABL1(T315I) mutant kinase.

doi: 10.1002/cmdc.201700829

Figure Lengend Snippet: Inhibition of cellular ABL1 activity by imatinib, ponatinib and HSN compounds

Article Snippet: Evaluation of compounds activity against ABL1 and ABL1(T315I) inside CML cell lines KCL22 and KCL22-IR (by KinaSense, West Lafayette, IN, USA).

Techniques: Inhibition, Activity Assay